Robert E. Gagnon - Insider Trading & Ownership

Location
C/O Biogen Idec Inc., 133 Boston Post Road, Weston, MA
Summary
The estimated net worth of Robert E. Gagnon is at least $701K dollars as of September 18, 2025. Robert E. Gagnon is the Director of Verastem, Inc. and owns shares of Verastem, Inc. (VSTM) stock worth about $419K. Robert E. Gagnon is the Chief Financial Officer of Opus Genetics, Inc. and owns shares of Opus Genetics, Inc. (IRD) stock worth about $192K. Robert E. Gagnon is the Director of Bone Biologics Corp and owns shares of Bone Biologics Corp (BBLG) stock worth about $49.1K. Robert E. Gagnon is the Director of HARVARD BIOSCIENCE INC and owns shares of HARVARD BIOSCIENCE INC (HBIO) stock worth about $40.7K.
Signature
/s/ Daniel Calkins, Attorney in Fact
All Insider Reports
All Insider Reports

Ownership of Robert E. Gagnon

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
VSTM Verastem, Inc. Director $419K -$8.25K -1.93% Sep 16, 2025
IRD Opus Genetics, Inc. Chief Financial Officer $192K Sep 2, 2025
BBLG, BBLGW Bone Biologics Corp Director $49.1K Jun 4, 2025
HBIO HARVARD BIOSCIENCE INC Director $40.7K Jul 16, 2025

Insider Transactions Reported by Robert E. Gagnon:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.